The use of the non-human primate in long-term studies of contraceptive steroids has been questioned because of time, expense and apparent lack of results predictive for humans. Controversies have arisen primarily over the occurrence of mammary nodules in studies of different contraceptive steroids and the occurrence of uterine tumors in 2 high-dose group monkeys in the Depo-Provera study. The long-term studies have been criticized because of the experimental design and the small number of monkeys per dose group, Individual studies by themselves did not reveal lesions other than those expected from an exaggerated pharmacologic response of target tissues; however, a pattern may emerge from reviewing and combining results of different studies that indicate the results of these studies are in agreement with the clinical findings in man. Effects of contraceptive steroids on the mammary gland and genital organs will be discussed. Data from 17 contraceptive steroid studies involving 264 untreated control and 733 treated non-human primates were available.
several long-term monkey contraceptive studies and as a pathologist on 4 long-term contraceptive studies in monkeys. Data were available from 17 contraceptive steroid studies involving 264 untreated control monkeys and 733 treated monkeys; however, much of the information is limited and sketchy.
In 1973,26 studies had been initiated in monkeys (1) . The results of only 1 10-yr oral toxicity study in rhesus monkeys have been reported in the literature, namely Norlestrin by Fitzgerald et a1 (5 Table I . The components of the contraceptive steroids and the abbreviations used in the studies reviewed are listed in Table 11 . The individual studies, the components of the formulations and the number of monkeys on each study are presented in Table 111 . The rhesus monkey (Macaca inirlatta) was most commonly used in regulatory studies; however, the baboon (Papio sp.) and more recently the cynomolgus monkey (Macaca fascicztrlaris), because of rhesus monkey supply problems, have also been used. Controversies about the carcinogenic hazards of contraceptive steroids have centered on the interpretations of the lesions and the appropriateness of the tests in animals for correctly predicting carci- nogenicity in man. The influence of contraceptive steroids on tumorigenesis in the reproductive organs in experimental animals seems to depend on the susceptibility of the species and strain, age and sex of the animal, diet and housing conditions and especially on the species-specific metabolic pattern of the substance administered, dosage, mode of administration, continuity and duration of treatment (4).
E m a s OF CONTRACEPTIVE STEROIDS ON SELECTED NON-HUMAN PRIMATE TISSUES Eflects oil the Maminary GIaiid
The mammary gland in macaques extends in a single plane of tissue from the sternum laterally to the anterior axillary line and from the clavicle to the lower margin of the ribs (20) . Spontaneous tumors of the mammary gland have been reported in macaques and other non-human primate species (1 6). Spontaneously occurring mammary carcinomas in 4 rhesus monkeys in a laboratory colony (Litton Bionetics, Inc., Rockville, MD) behaved as expected with progressive growth, ulceration, infiltrative growth into surrounding tissues and metastases.
The mammary gland received considerable attention in the evaluation of contraceptive steroids. Palpable nodules occurred in many of the studies in control and treated monkeys. Protocols recommended monthly palpation of mammary glands for the detection of nodules. Nodules that were found in these studies would rarely have been detected in the colony-kept monkey unless they reached a size .
where they would be readily visualized, The smallest nodules were detected only with careful palpation and many of the nodules that were palpated were small lymph nodes near the axillary region. Nodules that persisted until termination were classified histologically in several categories. Most were hyperplastic lobules or focal nodular hyperplasia. Grossly evident mammary tissue was graded at necropsy in 4 studies. They were graded from 1 to 4. Grade 1 was essentially no mammary tissue evident, grade 2 was a small amount visible in a thin layer, grade 3 was a moderate amount up to 1 mm thickness, and grade 4 was the same amount as grade 3 but 1-2 mm thickness and milky fluid may or may not have been present. Mammary tissue was also graded histologically by the degree of lobular formation. Grades 1 and 4 are shown in Fig. 1 . Generally, the control and low-dose group (1 x human dose) monkeys had mammary tissue graded 1 and 2, whereas those in the mid-and high-dose groups were graded 2-4, depending upon the individual; components of the preparation.
With the exception of 1 .report in the literature by Kirschstein et a1 (12) , in which an 8-10-yr-old rhesus monkey developed a mammary carcinoma with metastases after treatment with Enovid for 18 months, mammary gland lesions in macaques administered contraceptive steroids have been limited to intraductal hyperplasia with or without papillary infolding, lobular hyperplasia and focal nodular hyperplasia (2). More recently, minimal to severe atypical proliferation has been described in rhesus monkeys in a series of long-term studies -with oral contraceptives initiated by the FDA (18) . Atypical proliferation, as described in their report, appears to correspond to intraductal hyperplasia and focal nodular hyperplasia as previously described (2). In fact, intraductal hyperplasia had been reported in biopsy specimens from this study previously (6) .
Terminology for mammary gland lesions in the studies reviewed varied depending upon the pathologist. Non-invasive adenocarcinoma was the most advanced mammary lesion. From the limited description of the lesions and the variety of lesions in these studies, most lesions would be classified into the categories of proliferative lesions described above. Duct ectasia, apocrine metaplasia and lactational changes were also present.
Focal nodular hyperplasia was first described in 2 control monkeys on a long-term contraceptive study (14) . The occurrence and incidence of histologically confirmed focal nodular hyperplasia in 4 long-term studies is presented in Table IV . These nodules consist of lobules with multiple intraductal solid and papillary proliferations of epithelial cells. A thin capsule of connective tissue generally surrounds the periphery ofthe nodules. Mitotic activity may be present. Many of these nodules are reported to appear and regress. At least 1 monkey with histologically confirmed focal nodular hyperplasia was followed for 5 yr after excision of some of her multiple 0.5-2.0-cm nodules. She died of unrelated disease with no evidence of mammary nodules (1 1). Intraductal hyperplasia, with or without papillary formation, was present in up to 42% of the mammary glands in control monkeys on 4 long-term studies ( Table V) . In monkeys on the 3 studies administered a combination formulation containing an estrogen, an increased incidence of intraductal hyperplasia is evident. These figures do not correlate severity. Minimal and marked intraductal hyperplasia is illustrated in Fig. 1 . Ductal hyperplasia with papillary formation resembles duct papillomatosis of the juvenile human breast as described by Kiaer et a1 (10) . Intraductal dysplasia was described in 16 aging Macaca nemestrina in an investigation of the usefulness of this macaquenas an experimental mod-; el ofnormal and pathologic mammary development in the human (20) .
Intraductal hyperplasia'appears to correspond to minimal to moderate proliferative atypia described by Tavassoli et a1 (1 8) . Nodular hyperplasia corresponds to severe proliferative atypia. Severe proliferative atypia included lesions that would be classified as intraductal carcinoma and invasive carcinoma in the human breast.
Eflects on the Cervix
The cervix ofthe rhesus monkey is relatively large and conspicuous. The infravaginal portion is a wellmarked protuberance with a transverse, slit-like orifice that points slightly posteriorly. The posterior lip is approximately twice as thick as the anterior one. The posterior fornix is deeper than the anterior one. The endocervical canal is serpentine because of the intrusion of the large anterior colliculus. The vestibular cervical recess is filled with grossly visible mucus (21) . In monkeys administered contraceptive steroids, the cervix shows a treatment-and dose-related increase in mucus secretion by the endocervical epithelium and retention of viscid mucin. The higher the dose or the more potent the progestin, the more pronounced are the changes (Table VI) . Individual instances of adenoma, fibroadenoma, endocemical polyp and adenomatous polyp were reported without relation to treatment.
Efects on the Endonietritim atid Utertis
The effect of contraceptive steroids on the endometrium varies with the steroid components of the contraceptive, the potency of each hormone, the dose used, the length of treatment and the endogenous hormonal status of the individual monkey. Histologic evaluation of uteri from monkeys dying during the study or those from interim kills shows that the general pattern was usually established early in the study. Variation from diffuse atrophy of the endometrium to diffuse marked decidualization of the functional endometrium was evident. Endometria from monkeys receiving low-dose combination preparations were more often in the proliferative phase of the menstrual cycle, endometria from mid-dose monkeys were more variably , secretory and endometria from high-dose monkeys were more often atrophic. Endometria from monkeys receiving more potent progestins, such as medroxyprogesterone acetate and levonorgestrel, had basal atrophy with extensive superficial decidualization.
Uterine tumors occurred in 2 monkeys in each of 2 long-term studies with long-acting injectable progestins. Three of the 4 tumors were found at necropsy at termination of the 1 0-yr studies. One tumor. occurred in a monkey that died during the study. One monkey in each study had pulmonary metastases. These tumors will be discussed with species differences. The tumors do not appear histologically similar to spontaneously occurring endometrial tumors in other animals or man. It is plausible that they arose by a mechanism that does not have a .
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TOXICOLOGIC PATHOLOGY counterpart in man; however, this is speculative and is discussed under species differences.
Endometriosis, adenomyosis, leiomyoma and endometrial polyp are not uncommon in the rhesus monkey (3,16). The occurrences ofthese lesions are presented in Table VII . The incidence of endometriosis, adenomyosis and leiomyoma in 4 different studies decreased in the mid-and high-dose groups compared to the control and low-dose groups. This is more evident when the incidences from the 4 studies are combined and compared. The occurrence of endometrial polyps was more sporadic among groups within the studies and between studies.
Species Diflererices

I
Similarities in menstrual cycle, uterine morphology and placentation make the rhesus monkey and other Old World species valuable as experimental models in studies of human reproduction. There are significant differences that may affect long-term toxicity and carcinogenicity studies, however. The formation of an epithelial plaque in the endometrium during early implantation is a difference that must be taken into consideration in studies of contraceptive steroids, This epithelial plaque or deci-I duomal reaction can bejnduced experimentally and has been observed to occur spontaneously in a nongravid endometrium, in much the same manner as occurs experimentally in rodent uteri.
The formation of the epithelial plaque during early implantation and the experimental induction of the plaque has been fully described (8, 15, 22) . The epithelial plaque bears a morphologic resemblance to uterine tumors in monkeys on long-term contraceptive studies (Figs. 2 and 3) .
The epithelial plaque is part of the uterine reaction. It involves proliferation of the surface epithelium and the mouths or necks of the uterine glands. The proliferating epithelium becomes sharply circumscribed nests and nodules of epithelial cells. They grow perpendicular to the surface or glandular lumina and can become isolated into clumps by stroma. Normally, after a finite time, the plaque reaches its maximum thickness and regression begins in the superficial portion of the plaque. Two zones are evident, a zone of involution superficially and a zone of hyperplasia basally. There is very little remaining of the extensive proliferation by 17-21 days after experimental induction and the remaining cells show evidence of degeneration.
Throughout its existence, the plaque bears a strik-. ing resemblance to certain tumors, i.e., carcinoma. It has been mistakenly diagnosed as carcinoma itz sitti of the endometrium. The nuclei and nucleoli are enlarged and often atypical cell types are present. The extensive growth and the presence of atypical mitoses are characteristics commonly associated with neoplasia; however, in the epithelial plaque, the characteristic tumor autonomy is lacking.
While the epithelial plaque has a finite life span, experiments have not been done in monkeys to evaluate the effect of prolonged exposure to high levels of progestins. Epithelial plaques have been observed in monkey uteri with intrauterine devices and have been diagnosed as a carcinoma in sitzi (9, 17, 19) . Monkeys with epithelial plaque formation have been observed in 8 contraceptive studies, 4 with intrauterine devices and 4 with contraceptive steroids. These 8 studies are in addition to that reported by Wadsworth et a1 (19) . They are listed below: 1) Epithelial plaques were present in 1 monkey in each of 3 studies with intrauterine devices, 8-wk study, 1-yr study and a 2-yr study (Fig. 3) .
2) Control rhesus monkey in a 10-yr contraceptive study; this monkey died during drug cycle 95 because ofendometnosis with fatal hemorrhage from an endometrioid cyst. 'Multiple foci of epithelial plaque were present in the endometrium (Fig. 2) .
3) Low-dose (human dose) rhesus monkey in a 10-yr contraceptive study; this monkey survived until the end of the study. At necropsy, she had extensive serosal endometriosis. Histologically, there were multiple areas of superficial epithelial plaque in the serosal endometriotic tissue.
4) Cynomolgus monkey receiving high-dose progestin as an implant; several foci ofepithelial plaque were present in the endometrium. The endometrium had marked decidual change.
5 ) Low-dose rhesus monkey in a 10-yr contraceptive study; focus of epithelial plaque was present in endometriotic tissue on ovary.
Tiitnor Incidence in Control arid Treated Monkeys or1 Contraceptive Sttidies
Historically, the non-human primate has been reported to have an extremely low incidence of spontaneous tumors. However, this is no longer felt to be true. The number of tumor citations in the literature has increased dramatically in the last 10-1 5 yr. Spontaneous tumors were recently surveyed (1 3).
Tumors and proliferative lesions cited in the contraceptive steroid studies reviewed are listed without reference to compound or study in Table VIII . With few exceptions, these tumors and proliferative lesions are considered spontaneous and not related to treatment.
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